PHAR NASDAQ
Pharming Group N.V.
1W: -6.8%
1M: -12.9%
3M: -31.9%
YTD: -43.1%
1Y: -36.6%
3Y: -30.0%
5Y: +0.5%
$9.75
-0.20 (-2.01%)
Weekly Expected Move ±6.1%
$9
$9
$10
$10
$11
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$426M
+6.4% ▲
5Y CAGR: +4.4%
Total Liabilities
$190M
+6.0% ▲
5Y CAGR: -0.3%
Shareholders Equity
$236M
+6.7% ▲
5Y CAGR: +9.4%
Cash & Investments
$153M
-8.8% ▼
5Y CAGR: -1.8%
Total Debt
$116M
+3.1% ▲
5Y CAGR: -2.7%
Net Debt
-$9M
-114.9% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $192M | $207M | $62M | $55M | $124M |
| Short-Term Investments | $0 | $0 | $152M | $113M | $29M |
| Cash & ST Investments | $192M | $207M | $213M | $168M | $153M |
| Net Receivables | $28M | $25M | $43M | $50M | $47M |
| Inventory | $27M | $42M | $57M | $56M | $55M |
| Other Current Assets | $227K | $213K | $0 | $0 | $851 |
| Total Current Assets | $249M | $278M | $316M | $278M | $255M |
| Property, Plant & Equip. | $33M | $39M | $33M | $23M | $20M |
| Goodwill & Intangibles | $84M | $75M | $71M | $61M | $115M |
| Long-Term Investments | $9M | $10M | $10M | $4M | $8M |
| Other Non-Current Assets | $1M | $1M | $2M | $2M | $80K |
| Total Non-Current Assets | $148M | $148M | $147M | $122M | $171M |
| Total Assets | $397M | $426M | $463M | $400M | $426M |
| — Liabilities — | |||||
| Accounts Payable | $8M | $9M | $16M | $10M | $90M |
| Short-Term Debt | $2M | $2M | $2M | $4M | $5M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $0 | $3M | $17M |
| Total Current Liabilities | $47M | $60M | $78M | $74M | $116M |
| Long-Term Debt | $139M | $132M | $137M | $78M | $93M |
| Other Non-Current Liab. | $165K | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $158M | $161M | $166M | $105M | $107M |
| Total Liabilities | $204M | $221M | $244M | $179M | $190M |
| — Equity — | |||||
| Common Stock | $7M | $8M | $8M | $8M | $7M |
| Retained Earnings | -$273M | -$256M | -$265M | -$275M | -$232M |
| Accumulated OCI | $3M | -$9M | -$2M | -$209K | $0 |
| Total Stockholders Equity | $193M | $205M | $219M | $221M | $236M |
| Total Liabilities & Equity | $397M | $426M | $463M | $400M | $426M |
| — Key Metrics — | |||||
| Total Debt | $162M | $167M | $172M | $112M | $116M |
| Net Debt | -$30M | -$41M | $110M | $57M | -$9M |
| Total Investments | $9M | $10M | $162M | $117M | $37M |